Dmitri Simberg
Concepts (345)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 33 | 2025 | 481 | 9.120 |
Why?
| | Liposomes | 20 | 2025 | 223 | 4.520 |
Why?
| | Complement Activation | 18 | 2025 | 415 | 4.150 |
Why?
| | Nanomedicine | 12 | 2025 | 47 | 4.050 |
Why?
| | Polyethylene Glycols | 14 | 2025 | 641 | 4.000 |
Why?
| | Dextrans | 13 | 2024 | 84 | 3.830 |
Why?
| | Complement C3 | 10 | 2024 | 209 | 3.440 |
Why?
| | Drug Delivery Systems | 16 | 2025 | 365 | 3.020 |
Why?
| | Doxorubicin | 7 | 2025 | 362 | 2.920 |
Why?
| | Ferric Compounds | 7 | 2025 | 56 | 2.230 |
Why?
| | Complement System Proteins | 11 | 2024 | 327 | 2.200 |
Why?
| | Drug Carriers | 10 | 2024 | 128 | 2.180 |
Why?
| | Magnetite Nanoparticles | 9 | 2019 | 30 | 2.100 |
Why?
| | Microbubbles | 7 | 2017 | 49 | 1.940 |
Why?
| | Neoplastic Cells, Circulating | 4 | 2017 | 80 | 1.720 |
Why?
| | Complement Inactivating Agents | 2 | 2025 | 63 | 1.520 |
Why?
| | Leukocytes | 5 | 2023 | 311 | 1.520 |
Why?
| | Macrophages | 8 | 2023 | 1547 | 1.490 |
Why?
| | Ferrosoferric Oxide | 4 | 2019 | 27 | 1.420 |
Why?
| | Mice, Inbred BALB C | 17 | 2021 | 1272 | 1.360 |
Why?
| | Receptors, Scavenger | 3 | 2016 | 23 | 1.260 |
Why?
| | Immunoglobulins | 3 | 2024 | 171 | 1.190 |
Why?
| | Scavenger Receptors, Class A | 3 | 2019 | 12 | 1.150 |
Why?
| | Opsonin Proteins | 2 | 2019 | 25 | 1.100 |
Why?
| | Immunoglobulin M | 3 | 2024 | 289 | 1.100 |
Why?
| | Mice | 35 | 2025 | 17787 | 1.100 |
Why?
| | Cell Membrane | 4 | 2019 | 738 | 1.080 |
Why?
| | Animals | 49 | 2025 | 36940 | 1.070 |
Why?
| | Cetuximab | 2 | 2018 | 98 | 1.060 |
Why?
| | Antibodies | 2 | 2019 | 410 | 1.050 |
Why?
| | Immunoglobulin G | 4 | 2025 | 893 | 1.040 |
Why?
| | Erythrocytes | 5 | 2019 | 700 | 0.980 |
Why?
| | Single-Domain Antibodies | 1 | 2025 | 15 | 0.940 |
Why?
| | Cell Separation | 2 | 2017 | 318 | 0.890 |
Why?
| | Antineoplastic Agents | 5 | 2019 | 2129 | 0.810 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2023 | 31 | 0.800 |
Why?
| | Receptors, Complement 3d | 1 | 2023 | 141 | 0.790 |
Why?
| | Glioblastoma | 2 | 2025 | 345 | 0.780 |
Why?
| | Contrast Media | 3 | 2017 | 467 | 0.770 |
Why?
| | Endothelium | 2 | 2022 | 123 | 0.770 |
Why?
| | Cell-Penetrating Peptides | 2 | 2025 | 21 | 0.760 |
Why?
| | Lipids | 6 | 2022 | 672 | 0.750 |
Why?
| | Click Chemistry | 2 | 2019 | 49 | 0.740 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2024 | 852 | 0.730 |
Why?
| | Phosphatidylethanolamines | 5 | 2014 | 77 | 0.730 |
Why?
| | Neoplasms | 5 | 2024 | 2671 | 0.730 |
Why?
| | Quaternary Ammonium Compounds | 5 | 2006 | 52 | 0.720 |
Why?
| | Complement Pathway, Alternative | 3 | 2017 | 122 | 0.720 |
Why?
| | Fatty Acids, Monounsaturated | 5 | 2006 | 54 | 0.720 |
Why?
| | Surface Properties | 7 | 2018 | 413 | 0.710 |
Why?
| | Blood Proteins | 4 | 2019 | 252 | 0.710 |
Why?
| | Saccharomyces cerevisiae | 1 | 2025 | 557 | 0.680 |
Why?
| | Fluorocarbons | 3 | 2013 | 117 | 0.660 |
Why?
| | Macrophages, Peritoneal | 1 | 2019 | 94 | 0.620 |
Why?
| | Perfusion | 1 | 2020 | 213 | 0.620 |
Why?
| | Cell-Derived Microparticles | 1 | 2020 | 71 | 0.620 |
Why?
| | CD55 Antigens | 1 | 2019 | 30 | 0.620 |
Why?
| | Collagen Type II | 1 | 2019 | 53 | 0.620 |
Why?
| | Protein Corona | 1 | 2019 | 6 | 0.610 |
Why?
| | Cyclooctanes | 1 | 2018 | 5 | 0.610 |
Why?
| | Skin | 3 | 2020 | 752 | 0.610 |
Why?
| | Bone Marrow | 1 | 2020 | 286 | 0.600 |
Why?
| | Urinary Bladder | 2 | 2020 | 183 | 0.600 |
Why?
| | Humans | 54 | 2025 | 137585 | 0.600 |
Why?
| | Cell Line, Tumor | 12 | 2025 | 3412 | 0.590 |
Why?
| | Lymphocytes | 2 | 2020 | 397 | 0.580 |
Why?
| | Transfection | 4 | 2005 | 945 | 0.560 |
Why?
| | Intravital Microscopy | 1 | 2017 | 25 | 0.550 |
Why?
| | Antigens, Neoplasm | 4 | 2014 | 319 | 0.550 |
Why?
| | Monocytes | 1 | 2020 | 563 | 0.540 |
Why?
| | Biological Transport | 5 | 2020 | 418 | 0.540 |
Why?
| | Skin Absorption | 1 | 2017 | 12 | 0.540 |
Why?
| | Lipid Bilayers | 1 | 2018 | 98 | 0.530 |
Why?
| | Protein Binding | 8 | 2019 | 2224 | 0.530 |
Why?
| | Phagocytes | 3 | 2023 | 101 | 0.530 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2017 | 127 | 0.530 |
Why?
| | Brain Neoplasms | 2 | 2025 | 1238 | 0.530 |
Why?
| | Glioma | 1 | 2021 | 395 | 0.520 |
Why?
| | Inflammation Mediators | 1 | 2019 | 513 | 0.510 |
Why?
| | Coated Materials, Biocompatible | 1 | 2016 | 62 | 0.510 |
Why?
| | Mucous Membrane | 1 | 2017 | 125 | 0.510 |
Why?
| | Spectrometry, Fluorescence | 1 | 2017 | 168 | 0.500 |
Why?
| | Particle Size | 5 | 2018 | 394 | 0.500 |
Why?
| | Liver | 3 | 2023 | 1943 | 0.500 |
Why?
| | Superoxide Dismutase | 1 | 2018 | 346 | 0.480 |
Why?
| | Neovascularization, Pathologic | 2 | 2015 | 301 | 0.480 |
Why?
| | Fluorescent Dyes | 6 | 2021 | 321 | 0.480 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 2 | 2015 | 77 | 0.470 |
Why?
| | Macrophages, Alveolar | 1 | 2018 | 391 | 0.460 |
Why?
| | Arthritis, Rheumatoid | 2 | 2025 | 1167 | 0.450 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2017 | 190 | 0.450 |
Why?
| | Ligands | 2 | 2014 | 664 | 0.440 |
Why?
| | Neutrophils | 1 | 2020 | 1238 | 0.440 |
Why?
| | Immunomagnetic Separation | 1 | 2013 | 5 | 0.410 |
Why?
| | Polymers | 1 | 2017 | 490 | 0.410 |
Why?
| | Tissue Distribution | 4 | 2017 | 332 | 0.400 |
Why?
| | Rats | 4 | 2025 | 5647 | 0.390 |
Why?
| | Complement C1q | 3 | 2022 | 37 | 0.390 |
Why?
| | Dogs | 2 | 2025 | 413 | 0.380 |
Why?
| | Mice, Inbred C57BL | 9 | 2021 | 5757 | 0.380 |
Why?
| | Epithelial Cell Adhesion Molecule | 4 | 2017 | 13 | 0.380 |
Why?
| | Receptors, Complement 3b | 2 | 2023 | 84 | 0.380 |
Why?
| | Biomarkers, Tumor | 2 | 2020 | 1276 | 0.360 |
Why?
| | Female | 22 | 2025 | 73304 | 0.330 |
Why?
| | Antibodies, Monoclonal | 2 | 2014 | 1430 | 0.320 |
Why?
| | Kallikrein-Kinin System | 1 | 2009 | 1 | 0.320 |
Why?
| | Breast Neoplasms | 2 | 2021 | 2253 | 0.310 |
Why?
| | Flow Cytometry | 2 | 2025 | 1178 | 0.310 |
Why?
| | Oxides | 1 | 2009 | 46 | 0.300 |
Why?
| | Arthritis, Experimental | 2 | 2020 | 147 | 0.290 |
Why?
| | Lymphoma, B-Cell | 1 | 2009 | 106 | 0.290 |
Why?
| | Cells, Cultured | 4 | 2023 | 4193 | 0.280 |
Why?
| | Neoplasms, Experimental | 2 | 2020 | 176 | 0.260 |
Why?
| | Iron | 1 | 2009 | 313 | 0.260 |
Why?
| | Biomimetics | 1 | 2007 | 44 | 0.260 |
Why?
| | Male | 16 | 2025 | 67762 | 0.260 |
Why?
| | Complement Factor H | 2 | 2025 | 80 | 0.250 |
Why?
| | Cholesterol | 2 | 2005 | 410 | 0.250 |
Why?
| | Cations | 3 | 2006 | 84 | 0.250 |
Why?
| | Drug Stability | 4 | 2017 | 167 | 0.230 |
Why?
| | Gentamicins | 1 | 2025 | 54 | 0.230 |
Why?
| | Antibodies, Bispecific | 1 | 2025 | 55 | 0.230 |
Why?
| | Synovial Membrane | 1 | 2025 | 117 | 0.220 |
Why?
| | Proteomics | 2 | 2021 | 1111 | 0.220 |
Why?
| | Complement C5 | 1 | 2024 | 81 | 0.220 |
Why?
| | Complement C5a | 1 | 2024 | 71 | 0.220 |
Why?
| | Complement Membrane Attack Complex | 1 | 2024 | 39 | 0.220 |
Why?
| | Complement C3a | 1 | 2024 | 42 | 0.220 |
Why?
| | T-Lymphocytes | 2 | 2025 | 1996 | 0.220 |
Why?
| | Half-Life | 2 | 2014 | 164 | 0.210 |
Why?
| | Cell Adhesion Molecules | 3 | 2014 | 181 | 0.210 |
Why?
| | DNA, Recombinant | 1 | 2003 | 47 | 0.210 |
Why?
| | Immunoassay | 1 | 2024 | 115 | 0.210 |
Why?
| | Middle Aged | 6 | 2025 | 33479 | 0.210 |
Why?
| | Recombinant Fusion Proteins | 2 | 2023 | 665 | 0.210 |
Why?
| | Polyamines | 3 | 2021 | 40 | 0.200 |
Why?
| | Ultrasonics | 2 | 2014 | 49 | 0.200 |
Why?
| | Spermine | 2 | 2005 | 27 | 0.200 |
Why?
| | DNA | 3 | 2009 | 1459 | 0.200 |
Why?
| | Pseudomonas Infections | 1 | 2025 | 225 | 0.200 |
Why?
| | Urinary Tract Infections | 1 | 2025 | 188 | 0.190 |
Why?
| | Adult | 7 | 2025 | 37929 | 0.190 |
Why?
| | Injections, Intravenous | 2 | 2017 | 206 | 0.190 |
Why?
| | Microscopy, Fluorescence | 2 | 2021 | 402 | 0.180 |
Why?
| | Biological Products | 1 | 2025 | 216 | 0.180 |
Why?
| | Dendrimers | 1 | 2021 | 18 | 0.180 |
Why?
| | Rats, Long-Evans | 1 | 2021 | 125 | 0.180 |
Why?
| | Diffusion | 2 | 2019 | 116 | 0.170 |
Why?
| | Temperature | 2 | 2014 | 679 | 0.170 |
Why?
| | Single-Chain Antibodies | 1 | 2020 | 18 | 0.170 |
Why?
| | Synoviocytes | 1 | 2020 | 16 | 0.170 |
Why?
| | Kupffer Cells | 2 | 2012 | 50 | 0.170 |
Why?
| | Models, Molecular | 3 | 2013 | 1570 | 0.170 |
Why?
| | Microscopy, Confocal | 1 | 2021 | 325 | 0.170 |
Why?
| | HEK293 Cells | 2 | 2013 | 730 | 0.160 |
Why?
| | Hindlimb | 1 | 2020 | 128 | 0.160 |
Why?
| | Testis | 1 | 2020 | 151 | 0.160 |
Why?
| | Multimodal Imaging | 1 | 2020 | 113 | 0.160 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2020 | 81 | 0.160 |
Why?
| | Hematinics | 1 | 2019 | 22 | 0.160 |
Why?
| | Joints | 1 | 2020 | 105 | 0.160 |
Why?
| | Phospholipids | 1 | 2021 | 223 | 0.160 |
Why?
| | Heterocyclic Compounds, 1-Ring | 1 | 2019 | 5 | 0.160 |
Why?
| | Foot | 1 | 2020 | 96 | 0.160 |
Why?
| | Fluorescein-5-isothiocyanate | 2 | 2009 | 35 | 0.160 |
Why?
| | Carbocyanines | 1 | 2019 | 33 | 0.160 |
Why?
| | Muscles | 1 | 2020 | 326 | 0.160 |
Why?
| | Complement C3-C5 Convertases | 1 | 2019 | 24 | 0.160 |
Why?
| | Magnetics | 2 | 2009 | 48 | 0.150 |
Why?
| | Bone Marrow Cells | 1 | 2020 | 316 | 0.150 |
Why?
| | Jurkat Cells | 1 | 2019 | 134 | 0.150 |
Why?
| | Prostate | 1 | 2020 | 175 | 0.150 |
Why?
| | Color | 1 | 2019 | 76 | 0.150 |
Why?
| | Lectins | 1 | 2019 | 49 | 0.150 |
Why?
| | Molecular Structure | 2 | 2018 | 489 | 0.150 |
Why?
| | Immunity, Innate | 3 | 2023 | 828 | 0.150 |
Why?
| | Opsins | 1 | 2018 | 10 | 0.150 |
Why?
| | Cell Movement | 1 | 2023 | 967 | 0.150 |
Why?
| | Femur | 1 | 2020 | 254 | 0.140 |
Why?
| | Endothelium, Vascular | 2 | 2023 | 927 | 0.140 |
Why?
| | Antirheumatic Agents | 1 | 2020 | 293 | 0.140 |
Why?
| | Archaeal Viruses | 1 | 2017 | 8 | 0.140 |
Why?
| | Equipment Design | 2 | 2017 | 522 | 0.140 |
Why?
| | Cartilage | 1 | 2019 | 188 | 0.140 |
Why?
| | Proteins | 2 | 2017 | 1009 | 0.140 |
Why?
| | Drug Liberation | 1 | 2017 | 35 | 0.140 |
Why?
| | MCF-7 Cells | 1 | 2017 | 124 | 0.140 |
Why?
| | Administration, Intravesical | 1 | 2017 | 15 | 0.140 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2025 | 872 | 0.130 |
Why?
| | Silicon Dioxide | 1 | 2018 | 115 | 0.130 |
Why?
| | Keratins | 1 | 2017 | 173 | 0.130 |
Why?
| | Camptothecin | 1 | 2017 | 116 | 0.130 |
Why?
| | Drug Compounding | 1 | 2017 | 101 | 0.130 |
Why?
| | Models, Animal | 1 | 2018 | 384 | 0.130 |
Why?
| | Optical Imaging | 1 | 2017 | 64 | 0.130 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2017 | 191 | 0.130 |
Why?
| | Inflammation | 2 | 2024 | 2837 | 0.130 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 250 | 0.120 |
Why?
| | Protein Conformation | 1 | 2019 | 934 | 0.120 |
Why?
| | Swine | 1 | 2018 | 775 | 0.120 |
Why?
| | Repressor Proteins | 1 | 2019 | 427 | 0.120 |
Why?
| | Sheep | 1 | 2018 | 856 | 0.120 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 422 | 0.120 |
Why?
| | Sodium Hydroxide | 1 | 2014 | 8 | 0.120 |
Why?
| | Complement Pathway, Classical | 1 | 2014 | 20 | 0.110 |
Why?
| | Cross-Linking Reagents | 1 | 2015 | 217 | 0.110 |
Why?
| | Complement Pathway, Mannose-Binding Lectin | 1 | 2014 | 26 | 0.110 |
Why?
| | Endocytosis | 1 | 2015 | 172 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1809 | 0.110 |
Why?
| | Umbilical Veins | 1 | 2014 | 62 | 0.110 |
Why?
| | Antigen-Antibody Reactions | 1 | 2014 | 55 | 0.110 |
Why?
| | Penicillinase | 1 | 2014 | 1 | 0.110 |
Why?
| | Nanoshells | 1 | 2014 | 1 | 0.110 |
Why?
| | Disease Models, Animal | 3 | 2025 | 4295 | 0.110 |
Why?
| | Bacillus cereus | 1 | 2014 | 5 | 0.110 |
Why?
| | Thrombosis | 2 | 2009 | 371 | 0.110 |
Why?
| | Leukocyte Reduction Procedures | 1 | 2014 | 26 | 0.110 |
Why?
| | Molecular Imaging | 1 | 2014 | 56 | 0.110 |
Why?
| | Kinetics | 1 | 2017 | 1670 | 0.110 |
Why?
| | Staurosporine | 1 | 2013 | 20 | 0.110 |
Why?
| | Nanocapsules | 1 | 2013 | 14 | 0.110 |
Why?
| | Molecular Targeted Therapy | 1 | 2017 | 411 | 0.110 |
Why?
| | Cells, Immobilized | 1 | 2013 | 21 | 0.110 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2013 | 33 | 0.100 |
Why?
| | Models, Biological | 2 | 2019 | 1783 | 0.100 |
Why?
| | Species Specificity | 1 | 2014 | 585 | 0.100 |
Why?
| | Lung | 3 | 2018 | 4060 | 0.100 |
Why?
| | Blood Cells | 1 | 2013 | 40 | 0.100 |
Why?
| | Gene Expression | 2 | 2012 | 1502 | 0.100 |
Why?
| | Molecular Conformation | 1 | 2013 | 145 | 0.100 |
Why?
| | Kininogens | 1 | 2012 | 6 | 0.100 |
Why?
| | Iron-Dextran Complex | 1 | 2012 | 7 | 0.100 |
Why?
| | Protein Kinase C | 1 | 2013 | 261 | 0.100 |
Why?
| | Mannose-Binding Lectins | 1 | 2012 | 11 | 0.090 |
Why?
| | Mannans | 1 | 2012 | 6 | 0.090 |
Why?
| | Blood Platelets | 1 | 2015 | 408 | 0.090 |
Why?
| | Lectins, C-Type | 1 | 2012 | 67 | 0.090 |
Why?
| | High-Energy Shock Waves | 1 | 2011 | 3 | 0.090 |
Why?
| | Pharmaceutical Vehicles | 1 | 2011 | 12 | 0.090 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1502 | 0.090 |
Why?
| | Collagen Type I | 1 | 2012 | 136 | 0.090 |
Why?
| | Mice, Knockout | 2 | 2017 | 3015 | 0.090 |
Why?
| | Cloning, Molecular | 1 | 2012 | 534 | 0.090 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2011 | 105 | 0.090 |
Why?
| | Mice, Transgenic | 2 | 2007 | 2167 | 0.080 |
Why?
| | Protein Structure, Tertiary | 1 | 2012 | 861 | 0.080 |
Why?
| | Receptors, Cell Surface | 1 | 2012 | 385 | 0.080 |
Why?
| | Models, Theoretical | 1 | 2013 | 578 | 0.080 |
Why?
| | Molecular Weight | 1 | 2009 | 335 | 0.080 |
Why?
| | Aged | 2 | 2025 | 23961 | 0.070 |
Why?
| | Nanostructures | 1 | 2009 | 107 | 0.070 |
Why?
| | Bacterial Proteins | 1 | 2014 | 879 | 0.070 |
Why?
| | Phosphatidylcholines | 2 | 2014 | 147 | 0.070 |
Why?
| | Enzyme Activation | 1 | 2009 | 810 | 0.070 |
Why?
| | Plasma | 1 | 2009 | 212 | 0.070 |
Why?
| | Carcinoma | 1 | 2009 | 240 | 0.070 |
Why?
| | United States | 1 | 2024 | 14841 | 0.060 |
Why?
| | Cell Line | 1 | 2012 | 2847 | 0.060 |
Why?
| | CpG Islands | 1 | 2006 | 157 | 0.060 |
Why?
| | Interleukin-13 Receptor alpha2 Subunit | 1 | 2025 | 6 | 0.060 |
Why?
| | Signal Transduction | 1 | 2019 | 5079 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 2 | 2020 | 3566 | 0.060 |
Why?
| | Iodine Radioisotopes | 1 | 2025 | 145 | 0.060 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2025 | 98 | 0.060 |
Why?
| | Serum Albumin | 1 | 2005 | 150 | 0.060 |
Why?
| | Adjuvants, Immunologic | 1 | 2005 | 226 | 0.060 |
Why?
| | Rheumatoid Factor | 1 | 2025 | 175 | 0.050 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2005 | 177 | 0.050 |
Why?
| | Micelles | 1 | 2004 | 39 | 0.050 |
Why?
| | Heparin | 1 | 2005 | 261 | 0.050 |
Why?
| | Biological Transport, Active | 1 | 2003 | 77 | 0.050 |
Why?
| | Biomarkers | 1 | 2014 | 4149 | 0.050 |
Why?
| | Luciferases | 1 | 2003 | 150 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2007 | 2139 | 0.050 |
Why?
| | Structure-Activity Relationship | 1 | 2004 | 570 | 0.050 |
Why?
| | Pseudomonas aeruginosa | 1 | 2025 | 352 | 0.050 |
Why?
| | Mannose-Binding Lectin | 1 | 2021 | 23 | 0.050 |
Why?
| | Glycerophospholipids | 1 | 2001 | 34 | 0.050 |
Why?
| | 3T3 Cells | 1 | 2001 | 163 | 0.050 |
Why?
| | Mannose-Binding Protein-Associated Serine Proteases | 1 | 2021 | 20 | 0.050 |
Why?
| | Circular Dichroism | 1 | 2001 | 149 | 0.040 |
Why?
| | Photoacoustic Techniques | 1 | 2020 | 6 | 0.040 |
Why?
| | Trastuzumab | 1 | 2021 | 96 | 0.040 |
Why?
| | Microscopy, Electron | 1 | 2001 | 443 | 0.040 |
Why?
| | Peptides | 1 | 2007 | 985 | 0.040 |
Why?
| | Phagocytosis | 1 | 2023 | 380 | 0.040 |
Why?
| | Influenza Vaccines | 1 | 2005 | 539 | 0.040 |
Why?
| | Bacteriophage lambda | 1 | 2021 | 88 | 0.040 |
Why?
| | Thymocytes | 1 | 2020 | 36 | 0.040 |
Why?
| | Luminescent Proteins | 1 | 2001 | 179 | 0.040 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2020 | 80 | 0.040 |
Why?
| | Mice, Inbred DBA | 1 | 2020 | 200 | 0.040 |
Why?
| | Plasmids | 1 | 2001 | 363 | 0.040 |
Why?
| | Theranostic Nanomedicine | 1 | 2020 | 15 | 0.040 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 107 | 0.040 |
Why?
| | Green Fluorescent Proteins | 1 | 2001 | 390 | 0.040 |
Why?
| | Microspheres | 1 | 2020 | 137 | 0.040 |
Why?
| | Positron-Emission Tomography | 1 | 2020 | 294 | 0.040 |
Why?
| | Nanotechnology | 1 | 2020 | 125 | 0.040 |
Why?
| | Receptor, ErbB-2 | 1 | 2021 | 341 | 0.040 |
Why?
| | Ultraviolet Rays | 1 | 2001 | 396 | 0.040 |
Why?
| | Apoptosis | 2 | 2020 | 2553 | 0.040 |
Why?
| | Pharmaceutical Preparations | 1 | 2020 | 179 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2018 | 155 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2001 | 518 | 0.040 |
Why?
| | Extremophiles | 1 | 2017 | 2 | 0.040 |
Why?
| | Immunity | 1 | 2018 | 143 | 0.040 |
Why?
| | Sulfolobus | 1 | 2017 | 11 | 0.040 |
Why?
| | RNA, Messenger | 1 | 2025 | 2833 | 0.030 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2017 | 156 | 0.030 |
Why?
| | Time Factors | 2 | 2006 | 6828 | 0.030 |
Why?
| | Lecithins | 1 | 2014 | 5 | 0.030 |
Why?
| | Peptides, Cyclic | 1 | 2014 | 259 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2014 | 363 | 0.020 |
Why?
| | Mice, Nude | 1 | 2013 | 698 | 0.020 |
Why?
| | Phantoms, Imaging | 1 | 2012 | 152 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2691 | 0.020 |
Why?
| | Cell Survival | 1 | 2013 | 1120 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2014 | 1164 | 0.020 |
Why?
| | Materials Testing | 1 | 2009 | 356 | 0.020 |
Why?
| | Salmon | 1 | 2006 | 22 | 0.020 |
Why?
| | NIH 3T3 Cells | 1 | 2006 | 144 | 0.020 |
Why?
| | Nasal Lavage Fluid | 1 | 2005 | 14 | 0.020 |
Why?
| | Oligodeoxyribonucleotides | 1 | 2006 | 143 | 0.020 |
Why?
| | Cholera Toxin | 1 | 2005 | 32 | 0.020 |
Why?
| | Hemagglutination Inhibition Tests | 1 | 2005 | 38 | 0.020 |
Why?
| | Polyelectrolytes | 1 | 2005 | 16 | 0.020 |
Why?
| | Administration, Intranasal | 1 | 2005 | 90 | 0.020 |
Why?
| | Spermatozoa | 1 | 2006 | 94 | 0.020 |
Why?
| | Influenza A Virus, H3N2 Subtype | 1 | 2005 | 45 | 0.020 |
Why?
| | Gene Transfer Techniques | 1 | 2006 | 170 | 0.010 |
Why?
| | Ceramides | 1 | 2005 | 118 | 0.010 |
Why?
| | Immunity, Mucosal | 1 | 2005 | 97 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1092 | 0.010 |
Why?
| | Rabbits | 1 | 2005 | 794 | 0.010 |
Why?
| | Genetic Therapy | 1 | 2006 | 297 | 0.010 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2005 | 148 | 0.010 |
Why?
| | Cattle | 1 | 2006 | 984 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 2006 | 658 | 0.010 |
Why?
| | Spleen | 1 | 2005 | 514 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2005 | 652 | 0.010 |
Why?
| | Antibodies, Viral | 1 | 2005 | 625 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2013 | 10811 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2005 | 2475 | 0.010 |
Why?
| | Cytokines | 1 | 2005 | 2085 | 0.010 |
Why?
|
|
Simberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|